Archives
-
From Biotech Chemist to Family Office to Biotech Pioneer – Sunil Shah’s Exciting Journey in Biotech
31 July, 2024
-
o2h Ventures Proud to be Shortlisted for the EISA Impact Award for a Second Year Running!
07 June, 2024
-
o2h Ventures Announces Seed Investment in AscendBio, A Company Advancing Therapies for Metabolic and Respiratory Diseases
03 May, 2024
-
o2h Ventures Invests in Vesynta, a Company Developing an AI Software to Maximise Therapeutic Potential and De-risk drug development
23 April, 2024
-
o2h Ventures invests in ClotProtect, a Company Developing Treatment to Improve Bleeding and Survival Outcomes
22 April, 2024
-
o2h Ventures Invests in Stratosvir – Advancing Viral Immunotherapy For Late-Stage Cancer
17 April, 2024
-
o2h Ventures Announces SEIS Investment in Innovative mRNA-Based Hearing Loss Treatment Company, CamGene Therapeutics
05 April, 2024
-
Pioneering innovation in biotech investments via o2h Ventures’ human health S/EIS funds
20 February, 2024
-
Fuelling academic innovation and fostering entrepreneurship
08 January, 2024
invest in the growth potential of UK life science & AI